HeartSciences (HSCS) Total Debt (2022 - 2026)

Name: HeartSciences (HSCS) Total Debt (2022 - 2026) | Business Quant
Creator: Business Quant

HeartSciences posted quarterly Total Debt of $421564.0 for Q1 2026, up 752.16% on a QoQ basis from $49470.0 in Q4 2024.

HeartSciences (HSCS) has 4 years of Total Debt data on file, last reported at $421564.0 in Q1 2026.

For the quarter ending Q1 2026, Total Debt changed N/A year-over-year to $421564.0; the trailing twelve-month figure through Jan 2026 stood at $421564.0 (changed N/A YoY), and the FY2023 full-year result was $500000.0, down 88.74% from the prior year.
Total Debt for Q1 2026 stood at $421564.0, up from $49470.0 in the prior quarter.
Across five years, Total Debt topped out at $4.4 million in Q2 2022 and bottomed at $49470.0 in Q4 2024.
The 4-year median for Total Debt is $500000.0 (2023), against an average of $1.1 million.
The widest annual swing landed in 2023, when Total Debt slumped 88.74%; it then changed 0.0% in 2024.
A 4-year view of Total Debt shows it stood at $1.0 million in 2022, then sank by 50.0% to $500000.0 in 2023, then sank by 90.11% to $49470.0 in 2024, then soared by 752.16% to $421564.0 in 2026.
The last three Total Debt figures came in at $421564.0 (Q1 2026), $49470.0 (Q4 2024), and $500000.0 (Q3 2024), per Business Quant data.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	34.05 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	14.72 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	8.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	10.13 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	1.93 Bn
10	HeartSciences	4.56 Mn	1.16 Mn	-	421,564.00

Download Data 🔒